What do current guidelines say about prescribing statins for the prevention of ASCVD in patients with HIV?
Better luck next time
The 2013 ACC/AHA guideline for preventing ASCVD states:
"The Expert Panel found extensive and consistent evidence supporting the use of statins for the prevention of ASCVD in many higher-risk primary- and all secondary-prevention individuals," in its section on Heart Failure.
"A high level of evidence supports the use of moderate-intensity statin therapy in persons who are 40 to 75 years of age," in its section on Diabetes.
"The evidence-based recommendations focus on patient groups who are well represented in RCTs and/or are highly likely to have high-risk genetic conditions, so the recommendations are designed to inform rather than replace clinical judgment," in its section on Limitations.
For more content, visit the Specialty Site.
Good job!